Trial Outcomes & Findings for A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy (NCT NCT01748890)
NCT ID: NCT01748890
Last Updated: 2017-10-20
Results Overview
From elastography-prostatectomy pathology correlation, the following data will be obtained, 1) The number of planned core biopsies that would intersect foci of prostate carcinoma, 2) The Gleason Score that would be obtained, assuming that elastographically targeted biopsies sample the targeted region.
TERMINATED
NA
4 participants
Participants will be followed until prostatectomy pathology is available (average 1 week)
2017-10-20
Participant Flow
Participant milestones
| Measure |
Sonoelastography
Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.
Sonoelastography: Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.
|
|---|---|
|
Overall Study
STARTED
|
4
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
| Measure |
Sonoelastography
Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.
Sonoelastography: Sonoelastography is an imaging technology predicated on reproducible differences in the backscattered ultrasound signal produced by compression of tissues of varying stiffness.
|
|---|---|
|
Overall Study
Insufficient recruitment for analysis
|
4
|
Baseline Characteristics
A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: Participants will be followed until prostatectomy pathology is available (average 1 week)Population: insufficient recruitment for analysis
From elastography-prostatectomy pathology correlation, the following data will be obtained, 1) The number of planned core biopsies that would intersect foci of prostate carcinoma, 2) The Gleason Score that would be obtained, assuming that elastographically targeted biopsies sample the targeted region.
Outcome measures
Outcome data not reported
Adverse Events
Sonoelastography
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place